Gabapentin for alcohol use disorder
Authors:
- 14 April 2021
- journal article
- editorial
- Published by The College of Family Physicians of Canada in Canadian Family Physician
- Vol. 67 (4) , 269
Abstract
Gabapentin treatment avoided more heavy drinking days (> 5 standard drinks/day) than placebo (27% vs 9%). Gabapentin can be a second-line, off-label option to treat AUD. However, there is mixed evidence and concerns about abuse-misuse, and drug-related harms.Keywords
This publication has 9 references indexed in Scilit:
- Pharmacologic treatment of alcohol use disorder2020
- Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in ScotlandBritish Journal of Anaesthesia, 2020
- Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal SymptomsJAMA Internal Medicine, 2020
- Trends in gabapentin and baclofen exposures reported to U.S. poison centersClinical Toxicology, 2019
- A meta‐analysis of the efficacy of gabapentin for treating alcohol use disorderAddiction, 2019
- Gabapentin misuseCanadian Medical Association Journal, 2019
- Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control studyPLOS Medicine, 2017
- Gabapentin misuse, abuse and diversion: a systematic reviewAddiction, 2016
- Alcohol Dosing and Total Mortality in Men and WomenArchives of internal medicine (1960), 2006